24/7 Market News Snapshot 22 July, 2025 – Polyrizon Ltd. Ordinary Shares (NASDAQ:PLRZ)

July 22, 2025

DENVER, Colo., 22 July, 2025 (www.247marketnews.com) – (Nasdaq:PLRZ) are discussed in this article.
Polyrizon Ltd. (Nasdaq:PLRZ) is experiencing significant momentum in the pre-market trading session, currently priced at $0.993, reflecting a 9.39% increase from the previous close of $0.908. This upward trend is complemented by a robust trading volume of 4.88 million shares, indicating strong investor interest and the potential for further gains. Traders are advised to monitor key support levels and volume patterns closely, as the recent breakout above resistance levels may signal a sustainable bullish trajectory for the stock within the biopharmaceutical sector.

In a notable development, Polyrizon has announced promising preclinical results for its PL-14 Allergy Blocker, part of its proprietary Capture & Contain (C&C) platform. Conducted in collaboration with the University of Parma, the preclinical study, led by Professor Fabio Sonvico, showcased PL-14’s targeted effectiveness against allergic rhinitis. By leveraging validated silicone-based human nasal casts and fluorescein-labeled imaging techniques, the study demonstrated an impressive deposition rate exceeding 60% in the nasal vestibule, illustrating PL-14’s capability to form a physical barrier against airborne allergens.

Tomer Izraeli, CEO of Polyrizon, highlighted the critical importance of these results, emphasizing that the C&C platform provides a concentrated hydrogel barrier right at the site of allergen exposure, marking a significant innovation in allergy prevention. As the global allergen blocker market is projected to grow from $0.14 billion in 2024 to $0.21 billion by 2033, the demand for effective allergy relief solutions continues to rise. Polyrizon’s strategic focus on advancing PL-14 toward clinical trials positions the company as a key player in the field of allergy management, further solidifying its commitment to addressing pressing health challenges.

Related news for (PLRZ)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.